Important Dates |
|
|---|---|
| Early Bird Abstract submissions Closes on November 29, 2025 | |
| Early Bird Registrations Closes on December 01, 2025 | |
| Abstract submissions Closes on February 01, 2026 | |
| Registrations Closes on March 09, 2026 | |
About Conference
Regenerative Medicine 2026
Regenerative Medicine and Stem Cell Research stand at the cusp of revolutionizing treatment paradigms through the repair, replacement, and regeneration of damaged tissues and organs. Globally, this multidisciplinary field combines stem cell research, gene therapy, tissue engineering, and bioengineering to address chronic diseases, injuries, and age-associated conditions. Global Regenerative Medicine 2026 brings together global leaders, innovators, and practitioners to share research highlights, address common challenges, and explore the next frontiers in regenerative medicine and stem cell research, with a special emphasis on the unique contributions and opportunities within Malaysia and ASEAN.
Regenerative Medicine and Stem Cell Research : Research Pain Points and Progress
Pain Points
• Complex frameworks have slowed therapeutic translation and approval processes
• Costs of research, development, and manufacturing impede rapid commercialization
• Identifying precise mechanisms of action and Therapeutic targets
• Ethical concerns, especially surrounding stem cell research and gene editing, influence public acceptance and policy
• Limited reimbursement strategies hinder patient access and market adoption
• Challenges in scaling homegrown innovations to global markets
Progress
• Integration of artificial intelligence and machine learning accelerates drug discovery and biomarker identification
• Advancements in cell therapy, stem cell research, and gene editing technologies such as CRISPR have expanded therapeutic potentials
• Emergence of trial-and-error translational models
• Growth in biomanufacturing technologies
